Advances in Diagnosis and Treatments for Immune Thrombocytopenia
about
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura.Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia.Percentages of PD-1+CD4+T cells and PD-L1+DCs are increased and sPD-1 level is elevated in patients with immune thrombocytopenia.
P2860
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@ast
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@en
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@nl
type
label
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@ast
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@en
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@nl
prefLabel
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@ast
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@en
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@nl
P2860
P3181
P356
P1476
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
@en
P2093
Shosaku Nomura
P2860
P3181
P356
10.4137/CMBD.S39643
P407
P577
2016-01-01T00:00:00Z